Ron Do

Search results

• Novel Genetic Priority Score Unveiled to Enhance Target Prioritization in Drug Development

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  3/01/24

  76 items of Media coverage

  Press/Media

• Genetic Priority Score Finetunes Drug Development

  Do, R.

  3/01/24

  1 item of Media coverage

  Press/Media

• Novel genetic priority score unveiled to enhance target prioritization in drug development

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  3/01/24

  4 items of Media coverage

  Press/Media

• Icahn School of Medicine Develops Innovative Tool to Optimize Drug Target Prioritization

  Do, R.

  3/01/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Novel Genetic Priority Score Unveiled to Enhance Target Prioritization in Drug Development

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  3/01/24

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Report Details of New Studies and Findings in the Area of Acute Pancreatitis (Severe Hypertriglyceridemia: Existing and Emerging Therapies)

  Do, R.

  29/12/23

  1 item of Media coverage

  Press/Media

• Samsung Medical Center Reports Findings in Colon Cancer (An atlas of associations between 14 micronutrients and 22 cancer outcomes: Mendelian randomization analyses)

  Do, R.

  5/09/23

  1 item of Media coverage

  Press/Media

• Findings from Massachusetts General Hospital Yields New Data on Preeclampsia (Polygenic Prediction of Preeclampsia and Gestational Hypertension)

  Do, R.

  14/08/23

  1 item of Media coverage

  Press/Media

• Data on Clinical Trial Research Reported by Researchers at Icahn School of Medicine at Mount Sinai (Clinical Trial Design for Triglyceride-rich Lipoprotein-lowering Therapies Jacc Focus Seminar 3/3)

  Do, R.

  20/06/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researcher Updates Current Study Findings on Lyme Disease (Cholesterol contributes to risk, severity, and machine learning-driven diagnosis of Lyme disease)

  Do, R.

  13/06/23

  1 item of Media coverage

  Press/Media

• Research from Icahn School of Medicine at Mount Sinai Provides New Study Findings on Autoimmunity (A machine learning model identifies patients in need of autoimmune disease testing using electronic health records)

  Nadkarni, G., Rocheleau, G., Do, R. & Park, J.

  16/05/23

  1 item of Media coverage

  Press/Media

• Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of Marijuana/Cannabis (Cannabis Use and Ckd: Epidemiological Associations and Mendelian Randomization)

  Rein, J., Dellepiane, S., Rein, J., Nadkarni, G., Do, R., Charney, A., Coca, S. & Rajagopal, M.

  12/05/23

  1 item of Media coverage

  Press/Media

• Q4 2022 Sanara Medtech Inc Earnings Call

  Do, R.

  22/03/23

  2 items of Media coverage

  Press/Media

• Q4 2022 Sanara Medtech Inc Earnings Call

  Do, R.

  22/03/23

  2 items of Media coverage

  Press/Media

• Recent Research from Icahn School of Medicine at Mount Sinai Highlight Findings in Heart Disease (Machine Learning-based Marker for Coronary Artery Disease: Derivation and Validation In Two Longitudinal Cohorts)

  Nadkarni, G., Rocheleau, G., Do, R. & Park, J.

  10/03/23

  1 item of Media coverage

  Press/Media

• Developing a digital marker for coronary artery disease

  Do, R.

  9/03/23

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Publish Findings in Marijuana/Cannabis (Cannabis Use and CKD: Epidemiological Associations and Mendelian RandomizationPlain-Language Summary)

  Rein, J., Dellepiane, S., Rein, J., Do, R., Charney, A., Coca, S. & Rajagopal, M.

  2/02/23

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai Machine

  Rocheleau, G., Do, R. & Park, J.

  27/12/22

  1 item of Media coverage

  Press/Media

• ‘Digital Biomarker,’ Derived From EHR, Can Diagnose and Describe CAD

  Do, R.

  27/12/22

  2 items of Media coverage

  Press/Media

• Mount Sinai researchers build computational marker for coronary heart disease

  Do, R.

  23/12/22

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  22/12/22

  1 item of Media coverage

  Press/Media

• Machine learning enables “clinically important” characterisation of coronary artery disease

  Do, R.

  22/12/22

  1 item of Media coverage

  Press/Media

• Machine Learning-Derived Model could Lead to Better Disease Screening, Diagnostics, and Management

  Rocheleau, G., Do, R. & Park, J.

  21/12/22

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  20/12/22 → 21/12/22

  2 items of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai Machine; Could lead to better disease screening, diagnostics, and management

  Rocheleau, G., Do, R. & Park, J.

  21/12/22

  19 items of Media coverage

  Press/Media